Abivax S.A. (ABVX) Stock Overview
Explore Abivax S.A.’s financial performance, market position, analyst ratings, and future outlook.
Abivax S.A. (ABVX)
Key Financials
Key Financials
Market Cap
6.7B
P/E Ratio
-18.32
EPS (TTM)
$-5.36
ROE
-1.65%
ABVX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Abivax S.A. (ABVX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 44.07, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $135.50.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -18.32 and a market capitalization of 6.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.